RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
The Market Outlook for Neurodegenerative Diseases
Sep 2010 - 137 pages - $3,835
Amyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sep 2011 - 80 pages - $3,500
Amyotrophic Lateral Sclerosis Therapy Area Pipeline Report
Nov 2010 - 144 pages - $1,495
Neurodegenerative Disease Market to 2017 - Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone will Restrain Growth
Oct 2011 - 145 pages - $3,500
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) - Pipeline Assessment and Market Forecasts to 2017
Nov 2010 - 35 pages - $2,000
Amyotrophic Lateral Sclerosis - Pipeline Review, Q1 2011
Feb 2011 - 69 pages - $500
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2011
Sep 2011 - 122 pages - $500
The Avicena Group, Inc. – Product Pipeline Review – H2 2011
Sep 2011 - 31 pages - $500
The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007
Jan 2007 - 236 pages - $2,250
The Stem Cell Market Outlook
Jun 2011 - 113 pages - $3,835
More Related Market Research Reports >>>

Your selection

Industry sector
Non-profit org./Government del
Legal del
Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Amyotrophic Lateral Sclerosis (Lou Gehri del
Year
1999 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us